Sandostatin LAR depot 30 MG KTS
Ended Awarded
- Contract number
- SPE2DX25FVJNY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $48,387
Award facts
- Contract value 100% obligated
- $48,386.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Sandostatin LAR Depot 30 mg kits, a specialty pharmaceutical product used in the treatment of acromegaly and neuroendocrine tumors. This firm fixed-price delivery order, valued at $48,386.59, represents a competitive award with no set-aside designation and is scheduled for completion by September 4, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen Drug Corp maintains an extensive portfolio of federal medical supply contracts, predominantly with the Defense Logistics Agency and its various divisions. The company's federal procurement capabilities span a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. The SPE2DX IDC serves as a global pharmaceutical support vehicle enabling the company to supply military healthcare programs worldwide, with anticipated modifications to the broader program through the establishment of Pharmaceutical Prime Vendor Global Program Generation V contracts planned by DLA Troop Support.
Quick answers
Who was awarded contract SPE2DX25FVJNY?
SPE2DX25FVJNY was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on September 3, 2025.
How much is contract SPE2DX25FVJNY worth?
The government has obligated $48,387 on SPE2DX25FVJNY.
Is contract SPE2DX25FVJNY an order under another contract?
Yes. SPE2DX25FVJNY is a delivery order under SPE2DX15D1022, an indefinite delivery contract.
Was contract SPE2DX25FVJNY competed?
The extent of competition for SPE2DX25FVJNY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award